Drug would block breakdown of nicotine, reducing urge to smoke

The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk

Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation

Researchers have put chemistry to work on a simple, inexpensive way to identify counterfeit antibiotics—a serious problem in the developing world

“High risk, high reward” is the kind of discovery Dr. Garry Grubbs seeks with a new experiment designed to rapidly identify the atomic structure of chiral molecules widely used in pharmaceutical drugs

The discovery could help scientists develop new pathways for plants to battle infection

Substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world

A team of researchers has developed a drug-delivery system that allows rapid response to heart attacks without surgical intervention

About 50 percent of people who reach the age of 85 will develop Alzheimer’s disease

The approach has the potential to dramatically accelerate the design of new drug candidates

Researchers highlight a significant increase in harmful side effects related to the use of commonly prescribed opioid painkillers in people with dementia, compared to those on a placebo

Insilico Medicine announced a research collaboration agreement with A2A Pharmaceuticals, Inc